Direxion HCM Tactical Enhanced US ETF
$42.95−0.63 (−1.43%)
- Expense ratio
- 1.18%
- Fund size
- $595M
- 1Y return
- +16.2%
- Yield · Last 12 months
- 0.55%
- Holdings
- 508
- Volume · 30D
- 0M sh
- NAV per share
- $41.11
- 52W range
The ETF.net HCMT Grade
Score 26 of 100 sits in the D band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.FScore 12Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.FScore 5Category rankRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.FScore 11Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.CScore 52Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.Not scoredDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.AScore 78Category rank
Our read on HCMT
DA market-timing model in ETF form. HCMT follows the HCM-BuyLine signal: leveraged exposure to a broad basket of US stocks when the trend is on, cash when it flips off. An all-in-or-all-out design few active US equity funds attempt.
The Fund seeks capital appreciation and enhanced returns across market cycles broadly correlated with U.S. equities. Its model shifts assets between U.S. equity securities and cash, using derivatives for leveraged exposure when allocated to equities.
Why people hold it
- One ticker, one decision rule. The HCM-BuyLine momentum signal moves the fund between derivative-boosted US equity exposure and cash, instead of leaving the timing call to you.
- The equity sleeve is broad, roughly 500 US stocks, so the leverage rides the whole market rather than a handful of names.
- Conventional 1940 Act fund wrapper: a standard 1099 rather than a K-1, with distributions paid quarterly.
Worth knowing
- The 1.18% expense ratio sits well above the typical active US equity ETF, and far above broad index-style peers like DFAU and DFAC that charge a fraction of it.
- Leverage magnifies losses as well as gains, and a model that steps to cash can be late in both directions: into the decline and out of the rebound.
- Launched in 2023 and thinly traded, so the live record is short and bid-ask spreads can run wider than the category's heaviest-volume names.
HCMT Holdings
- Stocks
- 508
- 71%
- QQQ SWAP ASSET LEG (QQQBCL)
Sectors
- Technology38.7%
- Financials12.1%
- Communication9.5%
- Consumer Discr.9.3%
- Health Care9.3%
- Industrials7.8%
- Cons. Staples4.5%
- Energy3.5%
- Utilities2.0%
- Real Estate1.8%
- Materials1.7%
Geography
- United States97.63%
- Ireland1.21%
- United Kingdom0.39%
- Switzerland0.31%
- Singapore0.26%
- Netherlands0.10%
- Bermuda0.08%
- Canada0.03%
HCMT Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | HCMT |
|---|---|
| Year to date | +13.5% |
| 1 month | +6.4% |
| 3 months | +3.5% |
| 1 year | +16.2% |
| 3 years | +23.5% |
| 5 years | — |
| 10 years | — |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | HCMT |
|---|---|---|
| 2026 YTD | +13.5% | |
| 2025 | +7.4% | |
| 2024 | +39.2% | |
| 2023 | +5.6% |
HCMT in the news
ETF.net Research hasn’t filed on HCMT yet — coverage lands here as it’s written.
HCMT Dividends
- 0.55%
- $0.24
- $0.0037 per share
- Quarterly
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Sep 22, 2026 | Pays Sep 29, 2026 | $0.0037 |
| Jun 23, 2026 | Jun 30, 2026 | $0.13 |
| Mar 24, 2026 | Mar 31, 2026 | $0.06 |
| Dec 23, 2025 | Dec 31, 2025 | $0.0087 |
| Sep 23, 2025 | Sep 30, 2025 | $0.04 |
| Jun 24, 2025 | Jul 1, 2025 | $0.05 |
| Mar 25, 2025 | Apr 1, 2025 | $0.06 |
| Dec 23, 2024 | Dec 31, 2024 | $0.06 |
| Dec 12, 2024 | Dec 19, 2024 | $0.75 |
| Sep 24, 2024 | Oct 1, 2024 | $0.06 |
| Jun 25, 2024 | Jul 2, 2024 | $0.06 |
| Mar 19, 2024 | Mar 26, 2024 | $0.05 |
HCMT Risk
- 25.1%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.59
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −36.3%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 1.60
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
HCMT Cost
- The middle half of US Active Equity funds
- Median 0.70%
105 of the 124 US Active Equity funds charge less.